These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1786795)

  • 1. Cardiovascular and side effects of flesinoxan in conscious hypertensive dogs. Modulation by prazosin.
    Huber S; Grohs JG; Raberger G
    Eur J Pharmacol; 1991 Sep; 202(1):1-7. PubMed ID: 1786795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of flesinoxan in anaesthetized and conscious dogs.
    Grohs JG; Fischer G; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):472-5. PubMed ID: 2366880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the cardiovascular effects and '5-HT syndrome' induced by MDL 73,975 and flesinoxan in the dog mediated by 5-HT1A receptors?
    Di Francesco GF
    Eur J Pharmacol; 1994 Sep; 262(3):205-15. PubMed ID: 7813585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-adrenoceptor blockade and/or 5-HT1A agonism during treadmill exercise in dogs.
    Grohs JG; Fischer G; Huber S; Raberger G
    J Auton Pharmacol; 1991 Apr; 11(2):101-7. PubMed ID: 1675216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of alpha 1-adrenoceptor blockade and/or 5-HT1A agonism on blood pressure and heart rate at rest and during exercise in hypertensive dogs.
    Grohs JG; Huber S; Fischer G; Raberger G
    J Auton Pharmacol; 1992 Jun; 12(3):157-64. PubMed ID: 1352778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of repeated administration of prazosin on its hypotensive effect and on renin release in conscious dogs. A comparison with urapidil.
    Beck A; Kraupp O; Bacher S; Seitelberger R; Raberger G
    Basic Res Cardiol; 1984; 79(5):579-87. PubMed ID: 6391463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of the central nervous system in the systemic and regional hemodynamics of two centrally acting hypotensive drugs, flesinoxan and clonidine, in the rat.
    Dabiré H; Richer C
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):605-13. PubMed ID: 1724539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic sympathoinhibition on carotid artery diameter of spontaneously hypertensive rats: effects of clonidine and flesinoxan.
    Dabiré H; Chamiot-Clerc P; Chaouche-Teyara K; Fournier B; Safar ME
    Clin Exp Pharmacol Physiol; 2000 Sep; 27(9):715-23. PubMed ID: 10972539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.
    Massingham R; Hayden ML
    Eur J Pharmacol; 1975 Jan; 30(1):121-4. PubMed ID: 1122933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal functional responses to 5-HT1A receptor agonist, flesinoxan, in anaesthetized, normotensive rat.
    Chamienia AL; Johns EJ
    Br J Pharmacol; 1994 May; 112(1):214-8. PubMed ID: 8032644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular and renal functional responses to the 5-HT1A receptor agonist flesinoxan in two rat models of hypertension.
    Chamienia AL; Johns EJ
    Br J Pharmacol; 1996 Aug; 118(8):1891-8. PubMed ID: 8864520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the hypotensive action of prazosin.
    Constantine JW; McShane WK; Scriabine A; Hess HJ
    Postgrad Med; 1975 Nov; Spec No():18-35. PubMed ID: 1197141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive action of 5-HT receptor agonists in the vitamin B6-deficient hypertensive rat.
    Lal KJ; Dakshinamurti K
    Eur J Pharmacol; 1993 Apr; 234(2-3):183-9. PubMed ID: 8482325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K; Baba A; Akima M; Koga T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1989; 299():169-84. PubMed ID: 2570554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Van den Buuse M
    Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of terazosin.
    Kyncl JJ
    Am J Med; 1986 May; 80(5B):12-9. PubMed ID: 2872801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors.
    Wouters W; Tulp MT; Bevan P
    Eur J Pharmacol; 1988 May; 149(3):213-23. PubMed ID: 2842163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of the flesinoxan subtype of serotonin C1a receptor agonist on the arterial pressure in rats].
    Piianzin AI; Popova NK; Markel' AL
    Farmakol Toksikol; 1991; 54(4):28-30. PubMed ID: 1786817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.